Stroke: 30 years of progress.
نویسنده
چکیده
In 3 decades, Stroke has evolved from a fledgling publication to the leading journal in the field. Many factors have contributed to this, particularly the succession of outstanding editors in chief. We begin a series on “Stroke: 30 Years of Progress,” wherein each editor recalls the highlights of his tenure, providing a unique view of the past 3 decades (see page 3 for Dr Millikan’s editorial). I shall conclude the series with an article on “Stroke: The Next 30 Years,” an attempt to glimpse into the future. The current editors began receiving new manuscripts on July 1, 2000, while Dr Mark Dyken, José Biller, MarieGermaine Bousser, and Hermes Kontos continued to deal with the manuscripts that they had received before that date. We thank them and the Editorial Board warmly for their willingness to serve past their term. This issue’s masthead lists the new editors and Editorial Board. Several assistant editors have been named, to broaden expertise and divide labor. Section editors will ensure that developments in their areas are highlighted in Stroke so that all important publications or developments related to stroke will be either published or commented on in our journal. We will be publishing quarterly summaries of systematic reviews on stroke from the Cochrane Library. The most clamoring issues will be tackled in a new section dealing with controversies. In the short term, we aim to introduce new features without reducing the number of original publications or increasing the number of pages. We are decreasing the word limit for articles from 6000 to 5000 words and introducing “Research Reports” of 1500 words and 15 references. We are offering seminars on “Writing for Stroke.” The first one took place at the 4th World Stroke Congress in Melbourne, Australia, on November 25, 2000. The goals are 3-fold: to offer guidance in scientific writing, to familiarize participants with Stroke policies, and to learn how the journal can best serve their needs, always keeping in mind that Stroke is published for the readers. We aim to build on the reputation that our predecessors earned for the journal. We begin with our ideas but would also like to hear yours. Let us know.
منابع مشابه
Stroke: the next 30 years.
The only safe prediction about stroke in the next three decades is that it will be very different. Progress largely depends on discovery, and discovery cannot be predicted. However, understanding from where we are coming may help guide where we are going. Each of the previous editors of Stroke has given his view of stroke and the journal during his tenure, providing a concise and unique chronic...
متن کاملAngiotensin-converting enzyme inhibitors for stroke prevention: is there HOPE for PROGRESS After LIFE?
In the 1990s, it was established that increasing blood pressure (BP) is a causal risk factor for stroke and that lowering BP by any major class of antihypertensive medication reduces the risk of first-ever stroke.1 In 2000 and 2001, it was established from the Heart Outcomes Prevention Evaluation (HOPE) trial and particularly the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) ...
متن کاملEffectiveness of family empowerment program on level of adherence to treatment regimens in stroke patients; a randomized controlled trial
Background: Different physical and mental complications in patients with stroke, and the chronic nature of the disease, require the presence of their family as the primary source of constant care and support at home. However, for many reasons, such as not receiving adequate support from the medical staff, families face many failures in managing the care programs. Aim: to investigate the effects...
متن کاملThe prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made?
Atrial fibrillation (AF) is a major risk factor for stroke, especially in the elderly. Increased life expectancies mean that AF-related stroke is a growing global public health concern. Improvements in the detection, treatment and prevention of the consequences of AF have occurred in recent years. However, the extent to which these improvements have impacted on the prevalence of AF, the risk of...
متن کاملA clinical study investigating the three months prognosis of patients with ischemic stroke treated with recombinant tissue plasminogen activator (rt-PA) and its effective factors
Objective: Currently, treating ischemic stroke by intravenous thrombolytic therapy has acceptable results in patients with stroke. This study aimed to evaluate the three months prognosis of patients treated with recombinant tissue plasminogen activator (rt-PA).Methods: This cross-sectional prospective study was conducted on 30 patients with cerebral ischemic stroke with the National Insti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Stroke
دوره 32 1 شماره
صفحات -
تاریخ انتشار 2001